Vertex Pharmaceuticals’ breakthrough in cystic ... drugs and drug combinations that can treat 90% of CF patients. CEO Reshma Kewalramani says Vertex aims to eventually reach all CF patients.

Biotech company Vertex Pharmaceuticals (NASDAQ ... to-severe acute pain,” said Reshma Kewalramani, M.D., Chief Executive Officer and President of Vertex. Founded in 1989 with a mission to ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval ... GET FOX BUSINESS ON THE GO BY CLICKING HERE Vertex CEO Reshma Kewalramani touted Journavx as the "first ...

Vertex Pharmaceuticals (NASDAQ ... How significant is FDA approval of Journavx for Vertex? Vertex CEO Reshma Kewalramani described the FDA approval of Journavx as "a historic milestone for ...